REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 16th, 2019 • Bristol Myers Squibb Co • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT dated May 16, 2019 (this “Agreement”) is entered into by and among Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), and, upon execution of the joinder agreement referred to below, Celgene Corporation, a Delaware corporation (“Celgene” or the “Guarantor”), and Morgan Stanley & Co. LLC, Barclays Capital Inc., Credit Suisse Securities (USA) LLC and Wells Fargo Securities, LLC as representatives (collectively, the “Representatives”) of the initial purchasers listed in Schedule I to the Purchase Agreement (as defined below) (the “Initial Purchasers”). The agreements of Celgene under this Agreement shall not become effective unless and until Celgene executes a joinder agreement to this Agreement, which joinder agreement shall be substantially in the form attached as Exhibit A to this Agreement (the “Joinder Agreement”), at which time such agreements shall become effective pursuant to the terms of the Joinder Agreement (and until such ti
